IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, announces the launch of CASSY®, a compact synthesizer designed to streamline radiopharmaceutical production processes. This new IBA solution is set to transform the way radiometals and radiotracers are produced.
CASSY®, Compact Automated Scalable SYnthesis, enhances efficiency in radiopharmaceuticals production especially radiometals, thanks to seamless integration into laboratory workflows, user-friendly interfaces and versatility for both purification and radiolabelling.
Its compact design enables up to six units to be stacked in a single standard hot cell. This feature not only saves valuable space but also increases overall production potential, making it ideal for laboratories with limited space. Additionally, CASSY®‘s versatility in handling a wide range of radioisotopes ensures it meets the diverse needs of today’s research and clinical requirements, providing adaptability for future innovations such as radiotheranostics.
Also Read: Slingshot Biosciences Launches TruCytes™ for CAR-T Assays
CASSY® uses specific cassettes from Fluidomica, an integrated IBA company specialized in the development, production, and sales of disposable cassettes for single use in radioisotopes and radiopharmaceuticals manufacturing. CASSY®’s cassettes are provided with all necessary components for processes: reagents, connections, and ancillaries.
Charles Kumps, President of IBA RadioPharma Solutions, stated, ” The introduction of CASSY® represents a pivotal advancement in our dedication to theranostic innovation. Leveraging state-of-the-art technology, CASSY® is engineered to enhance the production of radiometals. I am proud to announce that CASSY® is a game changer for radiopharmaceuticals manufacturing, delivering superior quality and more dependable results for patients.”
IBA continues to lead the radiopharmaceuticals industry with its dedication to innovation and excellence. The introduction of CASSY® is a testament to the company’s ongoing efforts to improve healthcare and patient outcomes worldwide.
Source: Globenewswire